Skip to content

GE HealthCare Technologies Inc.

Public company
Headquarters
CHICAGO, Illinois
Ticker
GEHC
CIK
0001932393

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

4
2 appointments, 2 departures

Last event

Nov 5, 2026
Executive departureChief Science and Technology Officer departs: Taha Kass-Hout

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
Chief Science and Technology OfficerTaha Kass-HoutNov 5, 2026Departed
CEOJeannette BankesOct 28, 2026Departed
directorPascal DesrochesSep 22, 2026Appointed
CFOWilliam K. GroganAug 18, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive departure

    Chief Science and Technology Officer departs: Taha Kass-Hout

    Taha Kass-Hout, Chief Science and Technology Officer of GE HealthCare Technologies Inc., resigns the role, effective December 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Science and Technology Officer

    Source: SEC 8-K, filed Nov 5, 2026

  2. Executive departure

    CEO departs: Jeannette Bankes

    Jeannette Bankes, President and CEO, Patient Care Solutions of GE HealthCare Technologies Inc., resigns the role, effective November 15, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: President and CEO, Patient Care Solutions

    Source: SEC 8-K, filed Oct 28, 2026

  3. Executive appointment

    director appointed: Pascal Desroches

    Pascal Desroches was named director of GE HealthCare Technologies Inc., effective January 4, 2027. The company reported the change in an 8-K that cites Item 5.02.

    Role: director

    Source: SEC 8-K, filed Sep 22, 2026

  4. Executive appointment

    CFO appointed: William K. Grogan

    William K. Grogan was named Chief Financial Officer of GE HealthCare Technologies Inc., effective September 14, 2026. William K. Grogan succeeds George A. Newcomb. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Financial Officer

    Source: SEC 8-K, filed Aug 18, 2026

Last verified Nov 8, 2026